ENGOT-en7/MaNGO/AtTEnd study

Results of the study presented by Professor Nicoletta Colombo, 21 October 2023, ESMO 2023 annual meeting, Madrid

AtTEnd: Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

Research development towards the early diagnosis of ovarian cancer

We share an article, recently published in SCIENCE Translational Medicine, which describes the first steps towards a non-invasive screening for ovarian cancer. In a proof-of-principle study Lara Paracchini and collaborators show how the research for "genomic instability" in the PAP test can anticipate, years in advance, the diagnosis of high-grade serous ovarian carcinoma, one of the most elusive and aggressive tumors.

ESGO Lifetime Achievement Award 2023

Congratulations Professor Nicoletta Colombo!

Nicoletta Colombo, member of the MaNGO Scientific Technical Committee and director of the Gynecologic Program of the European Institute of Oncology (IEO) is the first woman to receive the ESGO Lifetime Achievement Award for "her exceptional career dedicated to improving the health and well-being of women affected by gynecological cancers, through a permanent commitment to prevention and promotion of excellence in care and clinical research".

The Award was presented during the ESGO Annual Congress at Istanbul (September 2023).